FDA official logo
GSRS logo
PFDA official logo

CONATUMUMAB

  • UNII: 1P48L61KM0
  • Preferred Substance Name: CONATUMUMAB

  • 896731-82-1
  • AMG 655
  • AMG-655
  • AN MONOCLONAL XG1-048 (ARG(SUP 219),GLU(SUP 361),MET(SUP 363)).GAMMA.1 HEAVY CHAIN (225-215')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (231-231'':234-234'')-BISDISULFIDE DIMER
  • AN MONOCLONAL XG1-048 (ARG(SUP 219),GLU(SUP 361),MET(SUP 363)).GAMMA.1 HEAVY CHAIN (225-215')-DISULPHIDE WITH .KAPPA. LIGHT CHAIN (231-231'':234-234'')-BISDISULPHIDE DIMER
  • CONATUMUMAB [INN]
  • CONATUMUMAB [USAN]
  • CONATUMUMAB [WHO-DD]
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B (DEATH RECEPTOR 5, TRAIL-R2, CD262 ANTIGEN))
  • TRAIL-R2 MAB
  • TRAIL-R2-MAB
  • XG1-048

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo